Dr. Neha Chavan
Founder | CEO | Chief Scientist
Dr. Neha Chavan is a visionary pharmaceutical scientist, international speaker, and entrepreneur.
Dr. Neha invented and patented the world’s first pharmaceutical-grade medicine delivery platform capable of supporting full-spectrum plant extracts such as hemp and cannabis. Her breakthrough technology, Oneness OS®, enables the 100% solubilization of whole-flower full-spectrum plant extracts in water.
Before establishing Oneness Technologies, Dr. Neha received her Ph.D. in Pharmaceutical Drug Development and worked in big pharma filing patents on novel drug delivery systems. She also served as Chief Product Officer at a cannabis-focused company where she was involved in advancing formulations, processes, product development, market research, and clinical trials.
Since founding Oneness Technologies and serving as its CEO, Dr. Neha has guided Oneness from R&D through commercialization of its technology and brands across the United States and beyond. Dr. Neha flows in creative freedom with passion to invent plant-based medicines for supporting the well-being of humanity.
Alex is a top-strategy thought leader, lifelong entrepreneur, and serves as the CFO of Oneness Technologies. Alex holds experience commercializing novel technologies in Silicon Valley in the artificial intelligence and social media industries including working for LinkedIn through the Microsoft acquisition. Alex began his professional career in the hedge fund space in New York at age 19 and holds a finance degree from NYU Stern School of Business.
Co-Founder & CFO
Shailesh leads Oneness’ group targeting cannabinoid therapies for FDA approval Prior to Oneness, Shailesh led Johnson & Johnson’s pharmaceutical salesforce in Asia and served as President of Thesay Group. Shailesh has an expertise in managing clinical trials and filing new drug applications with the FDA and other international agencies.
Glenn Powers leads manufacturing, scale up, and quality assurance processes for both Oneness’ core technology business unit. Prior to Oneness, Glenn has led Quality Assurance for Novartis’ oncology therapeutics as well as a Quality Assurance lead for several drug products at Pfizer.
Director of Quality & Compliance
Dr. Anthony Sabatelli leads Oneness’ intellectual property team. Prior to Oneness, Anthony served as an IP counsel for Merck & Proctor and Gamble as well as general counsel for publicly graded biotech companies. Anthony holds a Ph.D. in organic chemistry from Yale and a J.D. from. Salmon Chase School of Law.
Dr. Anthony Sabatelli
Dauro Dorea oversees Oneness’ corporate legal strategy. Dauro holds experience representing multi-national corporations such as Samsung and supporting the international expansion of numerous corporations across South America, Europe, and Asia.
Dr. Brian Pattengale supports Oneness’ intellectual property team. He holds a Ph.D. in Physical and Material Chemistry from Marquette and completed a post-doc at Yale specializing in the intersection of material sciences, physics, and biochemistry.
Dr. Brian Pattengale
Dr. Mak Jawadekar is the former Director of Worldwide Biopharmaceutical Businesses at Pfizer where he led development and commercialization efforts for drugs such as Viagra and Zoloft. Mak has also served as a White House health advisor to every Presidential administration since Jimmy Carter.
Dr. Mak Jawadekar
Oneness is a pharmaceutical company applying a series of plant-derived therapeutics for FDA approval.
Oneness offers our phase-shift drug delivery platform, Oneness OS®, to consumer hemp and cannabis companies which enables full-spectrum 100% water-soluble finished products.
Discover Oneness Technologies' opportunities to partner and distribute our advanced and sophisticated plant-based technology.